Literature DB >> 21122503

Conception outcomes and opinions about pregnancy for men with inflammatory bowel disease.

Asaka Sato1, Makoto Naganuma, Keiko Asakura, Yuji Nishiwaki, Tomoharu Yajima, Tadakazu Hisamatsu, Yasushi Iwao, Toru Takebayashi, Mamoru Watanabe, Toshifumi Hibi.   

Abstract

BACKGROUND AND AIMS: Patients with inflammatory bowel disease (IBD) who want to have children are anxious to receive medical treatment. The consensus regarding pregnancy has not been surveyed for male IBD patients. The present study was investigated opinions among male IBD patients about pregnancy, conception and neonatal outcomes for partners.
METHODS: Subjects comprised 364 of 386 patients enrolled (94.3%). Subjects received a questionnaire regarding their opinions and thoughts about pregnancy. The course of partner's conceptions and presence of neonatal malformations was also surveyed.
RESULTS: The rate of live births for partners of male IBD patients was 91.6% (219/239). Most patients with CD (29/33; 88%) had their children after surgery had been performed. The rate of expressing hopes to have a child tended to be higher for patients with UC (93/128; 73%) than for patients with CD (61/97; 63%; p=0.21). Furthermore, the rate of hesitation was significantly higher in CD patients (34/107; 32%) than in UC patients (38/188; 20%; p=0.03).Patients considered that safety of medication (51%) and maintenance of remission (41%) was more important than receiving no treatment for IBD (19%) when planning to conceive. Mesalamine and infliximab were more favorable at conception than sulfasalazine and immunomodulators.
CONCLUSIONS: This is the first report to survey the thinking of male IBD patients regarding pregnancy. Most male IBD patients considered "maintaining remission" as important at conception. Our study provides important information for IBD patients and for the treating physician when planning to conceive.
Copyright © 2009 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 21122503     DOI: 10.1016/j.crohns.2009.10.004

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN: 1873-9946            Impact factor:   9.071


  7 in total

1.  Evidence-based clinical practice guidelines for inflammatory bowel disease.

Authors:  Katsuyoshi Matsuoka; Taku Kobayashi; Fumiaki Ueno; Toshiyuki Matsui; Fumihito Hirai; Nagamu Inoue; Jun Kato; Kenji Kobayashi; Kiyonori Kobayashi; Kazutaka Koganei; Reiko Kunisaki; Satoshi Motoya; Masakazu Nagahori; Hiroshi Nakase; Fumio Omata; Masayuki Saruta; Toshiaki Watanabe; Toshiaki Tanaka; Takanori Kanai; Yoshinori Noguchi; Ken-Ichi Takahashi; Kenji Watanabe; Toshifumi Hibi; Yasuo Suzuki; Mamoru Watanabe; Kentaro Sugano; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2018-02-10       Impact factor: 7.527

2.  A crossover-crossback prospective study of dibutyl-phthalate exposure from mesalamine medications and semen quality in men with inflammatory bowel disease.

Authors:  Feiby L Nassan; Brent A Coull; Niels E Skakkebaek; Michelle A Williams; Ramace Dadd; Lidia Mínguez-Alarcón; Stephen A Krawetz; Elizabeth J Hait; Joshua R Korzenik; Alan C Moss; Jennifer B Ford; Russ Hauser
Journal:  Environ Int       Date:  2016-08-26       Impact factor: 9.621

Review 3.  Inflammatory bowel diseases and human reproduction: a comprehensive evidence-based review.

Authors:  Stefano Palomba; Giuliana Sereni; Angela Falbo; Marina Beltrami; Silvia Lombardini; Maria Chiara Boni; Giovanni Fornaciari; Romano Sassatelli; Giovanni Battista La Sala
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

Review 4.  Evidence-based clinical practice guidelines for inflammatory bowel disease 2020.

Authors:  Hiroshi Nakase; Motoi Uchino; Shinichiro Shinzaki; Minoru Matsuura; Katsuyoshi Matsuoka; Taku Kobayashi; Masayuki Saruta; Fumihito Hirai; Keisuke Hata; Sakiko Hiraoka; Motohiro Esaki; Ken Sugimoto; Toshimitsu Fuji; Kenji Watanabe; Shiro Nakamura; Nagamu Inoue; Toshiyuki Itoh; Makoto Naganuma; Tadakazu Hisamatsu; Mamoru Watanabe; Hiroto Miwa; Nobuyuki Enomoto; Tooru Shimosegawa; Kazuhiko Koike
Journal:  J Gastroenterol       Date:  2021-04-22       Impact factor: 7.527

5.  Systematic review: the consequences of psychosocial effects of inflammatory bowel disease on patients' reproductive health.

Authors:  Satvinder Purewal; Sarah Chapman; Wladyslawa Czuber-Dochan; Christian Selinger; Helen Steed; Matthew J Brookes
Journal:  Aliment Pharmacol Ther       Date:  2018-11-08       Impact factor: 8.171

6.  Minor impact on fertility in men with inflammatory bowel disease: A National Cohort Study from Sweden.

Authors:  Emma Druvefors; Roland E Andersson; Ulf Hammar; Kalle Landerholm; Pär Myrelid
Journal:  Aliment Pharmacol Ther       Date:  2022-05-22       Impact factor: 9.524

7.  Impaired fertility in men diagnosed with inflammatory arthritis: results of a large multicentre study (iFAME-Fertility).

Authors:  Luis Fernando Perez-Garcia; Esther Röder; Robbert J Goekoop; Johanna M W Hazes; Marc R Kok; Hieronymus T W Smeele; Ilja Tchetverikov; Annette H M van der Helm-van Mil; Jos H van der Kaap; Petra Kok; Bouwe P Krijthe; Radboud J E M Dolhain
Journal:  Ann Rheum Dis       Date:  2021-08-09       Impact factor: 19.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.